Yi Jiang

2.4k total citations
65 papers, 1.6k citations indexed

About

Yi Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yi Jiang has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Yi Jiang's work include RNA modifications and cancer (12 papers), MicroRNA in disease regulation (9 papers) and Ferroptosis and cancer prognosis (9 papers). Yi Jiang is often cited by papers focused on RNA modifications and cancer (12 papers), MicroRNA in disease regulation (9 papers) and Ferroptosis and cancer prognosis (9 papers). Yi Jiang collaborates with scholars based in China, Israel and New Zealand. Yi Jiang's co-authors include Yicong Wan, Wenjun Cheng, Lin Zhang, Lizhi Lv, Jing Yang, Jinghe Lang, Zihan Zhang, Lan Zhu, Jinhui Liu and Wenjun Cheng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yi Jiang

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Jiang China 22 1.1k 611 300 269 141 65 1.6k
Chunyan Gu China 24 1.5k 1.4× 678 1.1× 276 0.9× 295 1.1× 114 0.8× 93 2.3k
Xuan Zhao China 24 659 0.6× 304 0.5× 220 0.7× 470 1.7× 55 0.4× 71 1.4k
Ding‐Sheng Jiang China 29 1.5k 1.4× 750 1.2× 885 3.0× 193 0.7× 109 0.8× 64 2.4k
Xinyu Wang China 20 1.0k 1.0× 864 1.4× 181 0.6× 169 0.6× 55 0.4× 69 1.5k
Tsung‐Ying Yang Taiwan 27 682 0.6× 285 0.5× 814 2.7× 828 3.1× 132 0.9× 88 1.9k
Yanqing Gong China 30 1.4k 1.3× 884 1.4× 502 1.7× 507 1.9× 66 0.5× 115 2.4k
Liming Tang China 22 636 0.6× 314 0.5× 139 0.5× 233 0.9× 35 0.2× 83 1.1k
Xiaoping Ji China 21 913 0.9× 486 0.8× 77 0.3× 97 0.4× 103 0.7× 59 1.6k

Countries citing papers authored by Yi Jiang

Since Specialization
Citations

This map shows the geographic impact of Yi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Jiang more than expected).

Fields of papers citing papers by Yi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Jiang. The network helps show where Yi Jiang may publish in the future.

Co-authorship network of co-authors of Yi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Jiang. A scholar is included among the top collaborators of Yi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Jiang. Yi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yi, Jiahui Gu, Yun Liao, et al.. (2024). Targeting NEDD8 suppresses surgical stress-facilitated metastasis of colon cancer via restraining regulatory T cells. Cell Death and Disease. 15(1). 8–8. 9 indexed citations
3.
Tan, Shanjun, Jiahao Xu, Junjie Wang, et al.. (2023). Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery. Journal of Cachexia Sarcopenia and Muscle. 14(2). 891–902. 7 indexed citations
4.
Wu, Danni, et al.. (2023). ARID1A loss induces P4HB to activate fibroblasts to support lung cancer cell growth, invasion, and chemoresistance. Cancer Science. 115(2). 439–451. 7 indexed citations
5.
Chen, Minyong, Shujuan Zhang, Songjing Shi, et al.. (2023). USP5 promotes lipopolysaccharide-induced apoptosis and inflammatory response by stabilizing the TXNIP protein. Hepatology Communications. 7(8). 10 indexed citations
7.
Luo, Bin, Zujun Que, Dan Qi, et al.. (2023). Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer. Biological Procedures Online. 25(1). 29–29. 16 indexed citations
8.
Guo, Xiaoning, et al.. (2022). Case Report: Primary Intraosseous Poorly Differentiated Synovial Sarcoma of the Femur. Frontiers in Oncology. 12. 754131–754131. 4 indexed citations
9.
Huang, Xinghua, et al.. (2022). Immune Analysis and Small Molecule Drug Prediction of Hepatocellular Carcinoma Based on Single Sample Gene Set Enrichment Analysis. Cell Biochemistry and Biophysics. 80(2). 427–434. 7 indexed citations
10.
Jiang, Yi, Jian Zhang, Dan Guo, et al.. (2020). Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia. SHILAP Revista de lepidopterología.
11.
Liu, Jinhui, Xing Chen, Yi Jiang, & Wenjun Cheng. (2020). Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer. International Immunopharmacology. 86. 106735–106735. 21 indexed citations
12.
Wang, Yaping, Xinlu Zhang, Hai Zhu, et al.. (2020). Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis. Translational Cancer Research. 9(4). 2801–2813. 5 indexed citations
13.
Li, Ran, et al.. (2019). Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta‐analysis. Cancer Medicine. 8(6). 2717–2729. 34 indexed citations
14.
15.
Liu, Jinhui, Siyue Li, Yi Jiang, et al.. (2019). <p><em>ITLN1</em> identified by comprehensive bioinformatic analysis as a hub candidate biological target in human epithelial ovarian cancer</p>. Cancer Management and Research. Volume 11. 2379–2392. 9 indexed citations
16.
Xi, Qiulei, Bo Zhang, Yi Jiang, et al.. (2016). Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia. Oncology Letters. 12(5). 4013–4020. 20 indexed citations
17.
Han, Jun, Yi Jiang, Xiao Liu, et al.. (2015). Dietary Fat Intake and Risk of Gastric Cancer: A Meta-Analysis of Observational Studies. PLoS ONE. 10(9). e0138580–e0138580. 66 indexed citations
18.
Lei, Yuan, Jun Han, Qingyang Meng, et al.. (2015). Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study. Oncology Reports. 33(5). 2261–2268. 83 indexed citations
19.
Yang, Fang, et al.. (2014). Rho GDP Dissociation Inhibitor Beta Promotes Cell Proliferation and Invasion by Modulating the AKT Pathway in Hepatocellular Carcinoma. DNA and Cell Biology. 33(11). 781–786. 14 indexed citations
20.
Zhou, Xiaocong, et al.. (2012). Invasive ductal breast cancer metastatic to the sigmoid colon. World Journal of Surgical Oncology. 10(1). 256–256. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026